Evaluation of nonneutralizing antibodies against factor VIII in severe haemophilia A patients from India

Haemophilia A is treated by replacement therapy with factor VIII (FVIII) concentrate. This strategy of treatment is ineffective in some patients due to the development of neutralizing antibodies (NNAs) against FVIII. The inhibitors have been identified to act against the functional domains of FVIII....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Coagul Fibrinolysis
Egile Nagusiak: David, Sachin, Mathews, Nitty S., Singh, G. Surender, Korula, Anu, Aboobacker, Fouzia Nambiatheyil, Abraham, Aby, George, Biju, Srivastava, Alok, Mathews, Vikram, Nair, Sukesh C.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115924/
https://ncbi.nlm.nih.gov/pubmed/31449137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MBC.0000000000000843
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak